Czech Technical University in Prague
The goal of this clinical trial is to test microwave metamaterial glucose sensor on blood samples. It means to compare the results of glucose values obtained by microwave metamaterial sensor and by standard biochemical analyzer.
Diabetes
In vitro full blood diagnostic test.
NA
Participants will include physiological and pathological populations. Participants donate approximately 5 ml of blood sample. Three sample tubes will be collected from ten adult participants. In the first test tube, the blood glucose content will be determined by a validated biochemical analyzer (Roche, Switzerland). In the remaining volume of the blood sample, the dielectric parameters (relative permittivity and conductivity) will be estimated using a coaxial probe (Keysight, USA). Microwave metamaterial sensors with 5, 7 and 9 unit cells will be loaded with blood samples and the specific scattering matrices will be obtained using a vector network analyzer. The main monitored outcome measure will be the phase of parameter S21.
Study Type : | INTERVENTIONAL |
Estimated Enrollment : | 21 participants |
Masking : | NONE |
Primary Purpose : | BASIC_SCIENCE |
Official Title : | Feasibility Evaluation - Blood Glucose Level Monitoring by Microwave Metamaterial Sensor in Blood Samples. |
Actual Study Start Date : | 2023-07-12 |
Estimated Primary Completion Date : | 2023-07-17 |
Estimated Study Completion Date : | 2023-09-01 |
Information not available for Arms and Intervention/treatment
Ages Eligible for Study: | 18 Years |
Sexes Eligible for Study: | ALL |
Accepts Healthy Volunteers: | 1 |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
Not yet recruiting
Regional Hospital Kladno, a.s.
Kladno, Central Bohemian, Czechia, 27201